发明名称 |
Interlaced method for treating cancer or a precancerous condition |
摘要 |
The present invention provides a method for treating a disease or condition in a mammal which comprises the steps of; administering a therapeutically effective amount of a T type calcium channel inhibitor to effectively slow or stop progression of eukaryotic cells through the S, G and M phases of the cell cycle to increase the proportion of the eukaryotic cells in the G phase, stopping administration of the T type calcium channel inhibitor for a period of time, and administering a dosage selected from the group consisting of a dosage of at least one chemotherapeutic agent, a dosage of radiation, and combinations thereof, to kill the proportion of eukaryotic cells progressing past the G phase of the cell cycle after the stopping of the administration of the T type calcium channel inhibitor. |
申请公布号 |
AU2010256442(A1) |
申请公布日期 |
2012.01.19 |
申请号 |
AU20100256442 |
申请日期 |
2010.06.04 |
申请人 |
TAU THERAPEUTICS LLC |
发明人 |
KROUSE, ANDREW J.;GRAY, LLOYD S.;MACDONALD, TIMOTHY;LINDEN, JOEL |
分类号 |
A61K31/70;A61K38/16;A61K48/00;A61P35/00 |
主分类号 |
A61K31/70 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|